PTC ANNOUNCES FOURTH FISCAL QUARTER AND FULL FISCAL YEAR 2024 RESULTS
PTC (NASDAQ: PTC) today reported financial results for its fourth fiscal quarter and full fiscal year ended September 30, ...
PTC (PTC) Q4 2024 Earnings Call Transcript
Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to today's PTC 2024 fourth quarter conference call. During this presen ...
USA Today3mon
What to know about the federal solar tax credit (2024 guide)
The tenant, the property owner, or both can claim the full credit, provided the improvements ... the ITC and the production tax credit (PTC). If a solar system is installed between 2022 and ...
Stockhouse1d
PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy
and the factors discussed in the "Risk Factors" section of PTC's most recent Annual Report on Form 10-K, as well as any updates to these risk factors filed from time to time in PTC's other filings ...
PTC-9: Maps, track, spaghetti models
Our next named storm – Helene – is expected to form this week as Potential Tropical ... but these are still in stock READ THE ...
Kiplinger1mon
States Sending Tax Rebate, 'Stimulus' Checks
To be eligible for a Winter Energy Relief Payment from Maine, which has concluded, you must have filed a 2021 Maine personal income tax return as a full-time ... comes in the form of a tax ...
FiercePharma27d
EU drug reviewers back Novo Nordisk’s FDA-rejected hemophilia drug, snub PTC’s Translarna again
Alhemo, for its part, works by allowing blood clots to form ... up at PTC Therapeutics’ Translarna, the latest in a series of European setbacks for the drug. CHMP first rejected a full approval ...
Finanznachrichten4mon
PTC Therapeutics, Inc.: PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Strong revenue performance, supporting increase in full-year revenue guidance to $750 -800 ... and the factors discussed in the "Risk Factors" section of PTC's most recent Annual Report on Form 10-K, ...
ClearPoint Neuro: Near-Term Volatility Is No Concern
ClearPoint Neuro reported strong YoY growth in Q3, but the stock reacted negatively. Check out my recommendation for CLPT ...
Q4 2024 PTC Inc Earnings Call
Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to today's PTC 2024 fourth-quarter conference call. (Operator Instructions) I would now like to turn the call over to ...
Finanznachrichten7h
PTC Therapeutics, Inc.: PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy
The gene therapy, which will be marketed in the United States with the brand name KEBILIDI (eladocagene exuparvovec-tneq), is indicated for the treatment of children and adults with AADC deficiency, ...
PTC Inc. (PTC) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call November 6, 2024 5:00 PM ETCompany ParticipantsMatt Shimao - Head of Investor RelationsNeil Barua ...